Pre-Open Movers 12/11: (PTI) (OLLI) (PLAB) Higher (ITRM) (GME) (PLCE) Lower (more...)

Go back to Pre-Open Movers 12/11: (PTI) (OLLI) (PLAB) Higher (ITRM) (GME) (PLCE) Lower (more...)

Choice Hotels (CHH) Raises Quarterly Dividend 4.7% to $0.225; 0.9% Yield

December 13, 2019 8:01 AM EST

Choice Hotels (NYSE: CHH) declared a quarterly dividend of $0.225 per share, or $0.9 annualized. This is a 4.7% increase from the prior dividend of $0.215.

The dividend will be payable on January 16, 2020, to stockholders of record on January 2, 2020, with an ex-dividend date of December 31,... More

Momenta Phama (MNTA) Announces Dr. Jane F. Barlow to Board

December 13, 2019 8:01 AM EST

Momenta Pharmaceuticals, Inc. (NASDAQ: MNTA) today announced the appointment of Jane F. Barlow, M.D., M.P.H., M.B.A. to its Board of Directors.

Dr. Barlows expertise in market access and commercial pricing will be invaluable as we continue to develop our pipeline of novel autoimmune therapeutics, said Craig Wheeler,... More

Aquestive Therapeutics Inc. (AQST) Prices 7M Share Common Offering at $5/Sh

December 13, 2019 5:43 AM EST

Aquestive Therapeutics, Inc. (NASDAQ: AQST) today announced the pricing of its public offering of 7,000,000 shares of common stock at a public offering price of $5.00 per share for aggregate gross proceeds of $35.0 million. All of the shares in the offering are being offered by Aquestive. In... More

Momenta Phama (MNTA) Prices 14.516M Share Common Offering at $15.50/Sh

December 12, 2019 8:03 AM EST

Momenta Pharmaceuticals, Inc. (NASDAQ: MNTA) today announced the pricing of its underwritten public offering of 14,516,130 shares of its common stock at the public offering price of $15.50 per share for total gross proceeds to Momenta of approximately $225.0 million. Momenta has granted the underwriters an option... More

Marinus Pharma (MRNS) Announces Elan Ezickson to Board

December 12, 2019 7:31 AM EST

Marinus Pharmaceuticals, Inc. (NASDAQ: MRNS) announced today that Elan Ezickson, has joined the Companys Board of Directors. Mr. Ezickson is a highly accomplished executive with over 30 years of experience in the life sciences industry across commercial, operational and strategic... More

BofA Securities Downgrades The Children's Place (PLCE) to Underperform

December 12, 2019 5:54 AM EST

BofA Securities analyst David Buckley downgraded The Children's Place (NASDAQ: PLCE) from Neutral to Underperform with a price target of $45.00.

For an analyst ratings summary and ratings history on The Children's Place... More